Lobos Daniela R, Vicuña Isabella A, Novik Victoria, Vega Claudia A
School of Nutrition and Dietetics, Faculty of Pharmacy, Universidad de Valparaíso, Valparaíso, Chile.
School of Medicine, Faculty of Medicine, Universidad de Valparaíso, Chile and School of Medicine, Universidad Andrés Bello, venue Viña del Mar, Chile.
Clin Nutr ESPEN. 2017 Aug;20:12-16. doi: 10.1016/j.clnesp.2017.04.082. Epub 2017 May 11.
The results of studies evaluating the metabolic effects of glycemic index (GI) in subjects with type 2 diabetes mellitus (DM2) have been contradictory. Consequently, the benefits of its application are controversial and polarized opinions of international organizations have been disclosed. The above situation leads this study to evaluate the acute effect of low and high GI breakfast on the glycemic response and satiety in subjects with DM2 under intensive insulin therapy (IIT).
A controlled, crossover and single-blind clinical trial was developed involving 10 obese subjects with DM2 under IIT, with a period of at least six months under IIT and with fast insulin prescription before breakfast. Subjects ingested on two different occasions a high or low GI breakfast. In both stages, glycemia was evaluated at 0 (basal), 30, 60 and 120 min, and satiety and satiation were evaluated through a visual analogue scale.
In contrast to high GI breakfast, the low GI meal generated a significant decrease of 46% for the area under the curve of glucose (Δ 1940 mg/dL × 120 min, p = 0.022) and in mean glycemia evaluated at 30, 60 and 120 min. Moreover, in the low GI stage 8 of 10 patients achieved a 2 h postprandial glycemia lower than 180 mg/dL, without statistical significance. A nonsignificant increase of 12.7% (Δ 1.06 cm, p = 0.271) in satiety at 120 min in the low GI stage was observed.
In contrast to high GI breakfast, the low GI breakfast generated a significantly lower glycemic response. This assay allowed for the contribution of more in depth nutritional recommendations for this group of patients. Registered under ClinicalTrials.gov Identifier no. NCT02881164.
评估血糖生成指数(GI)对2型糖尿病(DM2)患者代谢影响的研究结果相互矛盾。因此,其应用的益处存在争议,国际组织也表达了两极分化的观点。上述情况促使本研究评估在强化胰岛素治疗(IIT)下,低GI和高GI早餐对DM2患者血糖反应和饱腹感的急性影响。
开展了一项对照、交叉和单盲临床试验,纳入10名接受IIT的肥胖DM2患者,他们接受IIT至少6个月,且早餐前有快速胰岛素处方。受试者在两个不同场合分别摄入高GI或低GI早餐。在两个阶段,分别于0(基础)、30、60和120分钟评估血糖,并通过视觉模拟量表评估饱腹感和饱足感。
与高GI早餐相比,低GI餐使葡萄糖曲线下面积显著降低46%(Δ1940mg/dL×120分钟,p=0.022),且在30、60和120分钟评估的平均血糖也显著降低。此外,在低GI阶段,10名患者中有8名餐后2小时血糖低于180mg/dL,但无统计学意义。在低GI阶段,120分钟时饱腹感无显著增加,增加了12.7%(Δ1.06cm,p=0.271)。
与高GI早餐相比,低GI早餐产生的血糖反应显著更低。本试验为该组患者提供了更深入的营养建议。在ClinicalTrials.gov注册,标识符为NCT02881164。